This study reported improved experimental colitis in LGR4 mutant mice through inhibition of glycogen synthase kinase 3 beta (GSK-3β), indicating an important role of LGR4 in inflammatory bowel disease (IBD) recovery [72]. Here, GSK3B is linked to colitis.